Among the 64,721 men without prevalent diabetes, 10.9% developed diabetes, and its adjusted hazard ratio was 1.44 (95% CI: 1.34 to 1.55, P < 0.001) in men treated with GnRH agonists. This evidence concerns the gene GNRH1 and diabetes mellitus.